Evidence map›Paper›PMID 38097767›Full record

ArticleEuropean journal of human genetics : EJHG2024

Exome sequencing of ATP1A3-negative cases of alternating hemiplegia of childhood reveals SCN2A as a novel causative gene.

Eleni Panagiotakaki, Francesco D Tiziano, Mohamad A Mikati, Lisanne S Vijfhuizen, Sophie Nicole, Gaetan Lesca, Emanuela Abiusi, Agnese Novelli, Lorena Di Pietro, I.B.AHC Consortium and 16 more

Open access · greenAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Diseases (Basel, Switzerland) · 2026
    Review
  4. Loss of ANK3 Function Causes a Recessive Neurodevelopmental Disorder with Cerebellar Ataxia.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  5. Unique signatures of highly constrained genes across publicly available genomic databases.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  6. Article
  7. Using exomes better.European journal of human genetics : EJHG · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 16 institutions in 5 countries.

Eleni Panagiotakaki *Department of Paediatric Clinical Epileptology, Sleep Disorders and Functional Neurology, Member of the ERN EpiCare, University Hospitals of Lyon (HCL), Lyon, France.
Francesco D Tiziano *Institute of Genomic Medicine, Catholic University and Policlinico Gemelli, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy.
Mohamad A Mikati *Division of Pediatric Neurology and Developmental Medicine, Duke University, Durham, NC, USA.
Lisanne S VijfhuizenDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Sophie NicoleInstitute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.
Gaetan LescaDepartment of Medical Genetics, University Hospital of Lyon and Claude Bernard Lyon I University, Lyon France - Pathophysiology and Genetics of Neuron and Muscle (PNMG), UCBL, CNRS UMR5261 - INSERM U1315, Lyon, France.ORCID http://orcid.org/0000-0001-7691-9492
Emanuela AbiusiDepartment of Life Sciences and Public Health, Section of Genomic Medicine, Università Cattolica del Sacro Cuore, Roma, Italy.ORCID http://orcid.org/0000-0001-9028-012X
Agnese NovelliDepartment of Life Sciences and Public Health, Section of Genomic Medicine, Università Cattolica del Sacro Cuore, Roma, Italy.
Lorena Di PietroInstitute of Genomic Medicine, Catholic University and Policlinico Gemelli, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy.
I.B.AHC Consortium
IAHCRC Consortium
Aster V E HarderDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-5477-7232
Nicole M WalleyDepartment of Pediatrics, Division of Medical Genetics, Duke Health, Durham, NC, USA.
Elisa De GrandisDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
Anne-Lise PoulatPediatric Neurology Department, Member of the ERN EpiCARE, University Hospitals of Lyon (HCL), Lyon, France.
Vincent Des PortesPediatric Neurology Department, Member of the ERN EpiCARE, University Hospitals of Lyon (HCL), Lyon, France.
Anne LépineService de neuropédiatrie, Centre hospitalo universitaire de la Timone, Marseille, France.
Marie-Cecile NassogneInstitut des Maladies Rares, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.ORCID http://orcid.org/0000-0001-6936-1611
Alexis ArzimanoglouDepartment of Paediatric Clinical Epileptology, Sleep Disorders and Functional Neurology, Member of the ERN EpiCare, University Hospitals of Lyon (HCL), Lyon, France.ORCID http://orcid.org/0000-0002-7233-2771
Rosaria VavassoriEuro-Mediterranean Institute for Science and Technology I.E.ME.S.T., Palermo, Italy.ORCID http://orcid.org/0000-0002-1598-0692
Jan KoenderinkDepartment of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands.
Christopher H ThompsonDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Alfred L GeorgeDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Fiorella GurrieriDepartment of Medicine, Research Unit of Medical Genetics, Università Campus Bio-Medico di Roma, Roma, Italy.
Arn M J M van den MaagdenbergDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. A.M.J.M.van_den_Maagdenberg@lumc.nl.ORCID http://orcid.org/0000-0002-9310-5535
Erin L HeinzenDivision of Pharmacology and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. eheinzen@unc.edu.ORCID http://orcid.org/0000-0002-7268-8559
Hospices Civils de Lyon · FRLeiden University Medical Center · NLUniversità Cattolica del Sacro Cuore · ITNorthwestern University · USAgostino Gemelli University Polyclinic · ITCentre National de la Recherche Scientifique · FRCliniques Universitaires Saint-Luc · BEDuke Medical Center · USDuke University · USHôpital de la Timone · FRIstituto Euro Mediterraneo di Scienza e Tecnologia · ITIstituto Giannina Gaslini · ITRadboud University Nijmegen · NLUniversità Campus Bio-Medico · ITUniversité Claude Bernard Lyon 1 · FRUniversity of North Carolina at Chapel Hill · US

Funding

Project 3 - Development and investigation of murine models of channelopathy-associated epilepsyU54NS108874 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GEORGE, ALFRED L. · 2018 to 2022
$12.1M
NINDS NIH HHS U54 NS108874
6 · The paper itself

Abstract

Alternating hemiplegia of childhood (AHC) is a rare neurodevelopment disorder that is typically characterized by debilitating episodic attacks of hemiplegia, seizures, and intellectual disability. Over 85% of individuals with AHC have a de novo missense variant in ATP1A3 encoding the catalytic α3 subunit of neuronal Na

Indexed as

HemiplegiaMutation, MissenseExome SequencingGTP-Binding ProteinsHumansMutationNAV1.2 Voltage-Gated Sodium ChannelSodium-Potassium-Exchanging ATPaseTumor Suppressor ProteinsATP1A3 protein, humanGTP-Binding ProteinsNAV1.2 Voltage-Gated Sodium ChannelRHOBTB2 protein, humanSCN2A protein, humanSodium-Potassium-Exchanging ATPaseTumor Suppressor Proteins

Identifiers

PMID38097767
PMCPMC10853263
OpenAlexW4389741719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.